 |
|
|
  |
|
The
Need for Better Assessment
Some
clinical studies have suggested that women don't respond
as well as men to aggressive treatment for heart attack,
such as clot-dissolving drugs or surgery.10
However,
as pointed out in a recent review of these trials, the
apparently reduced effectiveness of these therapies may
have resulted from incorrect initial assessment. The authors
recommend increased use of cardiac markers, especially
troponins,
to clearly identify women with and without myocardial
infarction upon or at the time of admission.10
The more frequent use of these markers both in studying
and in treating heart disease in women may improve:10
| |
• |
The
management of heart disease in women |
| |
• |
The
understanding of women's response to various treatments |
| |
• |
The
understanding of the development of heart disease
in women |
Recent
research has also suggested that a marker of inflammation,
C-Reactive
Protein, may be especially useful when used in conjunction
with other tests in evaluating the risk of heart disease
in women and in identifying those who would benefit most
from lifestyle modifications or drug therapy to lower
cholesterol levels.
To learn more about risk factors and disease prevention,
click
here.
To learn more about diagnosing a heart attack, click
here.
References |
|
 |
 |
 |
|
|
